266 related articles for article (PubMed ID: 17098273)
1. Neurovirulence properties of recombinant vesicular stomatitis virus vectors in non-human primates.
Johnson JE; Nasar F; Coleman JW; Price RE; Javadian A; Draper K; Lee M; Reilly PA; Clarke DK; Hendry RM; Udem SA
Virology; 2007 Mar; 360(1):36-49. PubMed ID: 17098273
[TBL] [Abstract][Full Text] [Related]
2. Recombinant vesicular stomatitis virus vaccine vectors expressing filovirus glycoproteins lack neurovirulence in nonhuman primates.
Mire CE; Miller AD; Carville A; Westmoreland SV; Geisbert JB; Mansfield KG; Feldmann H; Hensley LE; Geisbert TW
PLoS Negl Trop Dis; 2012; 6(3):e1567. PubMed ID: 22448291
[TBL] [Abstract][Full Text] [Related]
3. Immune response in the absence of neurovirulence in mice infected with m protein mutant vesicular stomatitis virus.
Ahmed M; Marino TR; Puckett S; Kock ND; Lyles DS
J Virol; 2008 Sep; 82(18):9273-7. PubMed ID: 18614644
[TBL] [Abstract][Full Text] [Related]
4. Quantitative multiplex assay for simultaneous detection of the Indiana serotype of vesicular stomatitis virus and HIV gag.
Coleman JW; Ogin-Wilson E; Johnson JE; Nasar F; Zamb TP; Clarke DK; Hendry RM; Udem SA
J Virol Methods; 2007 Jul; 143(1):55-64. PubMed ID: 17382412
[TBL] [Abstract][Full Text] [Related]
5. Attenuation of recombinant vesicular stomatitis virus-human immunodeficiency virus type 1 vaccine vectors by gene translocations and g gene truncation reduces neurovirulence and enhances immunogenicity in mice.
Cooper D; Wright KJ; Calderon PC; Guo M; Nasar F; Johnson JE; Coleman JW; Lee M; Kotash C; Yurgelonis I; Natuk RJ; Hendry RM; Udem SA; Clarke DK
J Virol; 2008 Jan; 82(1):207-19. PubMed ID: 17942549
[TBL] [Abstract][Full Text] [Related]
6. Recombinant vesicular stomatitis virus as an HIV-1 vaccine vector.
Clarke DK; Cooper D; Egan MA; Hendry RM; Parks CL; Udem SA
Springer Semin Immunopathol; 2006 Nov; 28(3):239-53. PubMed ID: 16977404
[TBL] [Abstract][Full Text] [Related]
7. A Novel Chimeric Oncolytic Virus Vector for Improved Safety and Efficacy as a Platform for the Treatment of Hepatocellular Carcinoma.
Abdullahi S; Jäkel M; Behrend SJ; Steiger K; Topping G; Krabbe T; Colombo A; Sandig V; Schiergens TS; Thasler WE; Werner J; Lichtenthaler SF; Schmid RM; Ebert O; Altomonte J
J Virol; 2018 Dec; 92(23):. PubMed ID: 30232179
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of attenuated vesicular stomatitis virus vectors expressing HIV type 1 Env and SIV Gag proteins: comparison of intranasal and intramuscular vaccination routes.
Egan MA; Chong SY; Rose NF; Megati S; Lopez KJ; Schadeck EB; Johnson JE; Masood A; Piacente P; Druilhet RE; Barras PW; Hasselschwert DL; Reilly P; Mishkin EM; Montefiori DC; Lewis MG; Clarke DK; Hendry RM; Marx PA; Eldridge JH; Udem SA; Israel ZR; Rose JK
AIDS Res Hum Retroviruses; 2004 Sep; 20(9):989-1004. PubMed ID: 15585086
[TBL] [Abstract][Full Text] [Related]
9. Synergistic attenuation of vesicular stomatitis virus by combination of specific G gene truncations and N gene translocations.
Clarke DK; Nasar F; Lee M; Johnson JE; Wright K; Calderon P; Guo M; Natuk R; Cooper D; Hendry RM; Udem SA
J Virol; 2007 Feb; 81(4):2056-64. PubMed ID: 17151112
[TBL] [Abstract][Full Text] [Related]
10. Priming with plasmid DNAs expressing interleukin-12 and simian immunodeficiency virus gag enhances the immunogenicity and efficacy of an experimental AIDS vaccine based on recombinant vesicular stomatitis virus.
Egan MA; Chong SY; Megati S; Montefiori DC; Rose NF; Boyer JD; Sidhu MK; Quiroz J; Rosati M; Schadeck EB; Pavlakis GN; Weiner DB; Rose JK; Israel ZR; Udem SA; Eldridge JH
AIDS Res Hum Retroviruses; 2005 Jul; 21(7):629-43. PubMed ID: 16060834
[TBL] [Abstract][Full Text] [Related]
11. Vaccination With a Highly Attenuated Recombinant Vesicular Stomatitis Virus Vector Protects Against Challenge With a Lethal Dose of Ebola Virus.
Matassov D; Marzi A; Latham T; Xu R; Ota-Setlik A; Feldmann F; Geisbert JB; Mire CE; Hamm S; Nowak B; Egan MA; Geisbert TW; Eldridge JH; Feldmann H; Clarke DK
J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S443-51. PubMed ID: 26109675
[TBL] [Abstract][Full Text] [Related]
12. Highly effective control of an AIDS virus challenge in macaques by using vesicular stomatitis virus and modified vaccinia virus Ankara vaccine vectors in a single-boost protocol.
Ramsburg E; Rose NF; Marx PA; Mefford M; Nixon DF; Moretto WJ; Montefiori D; Earl P; Moss B; Rose JK
J Virol; 2004 Apr; 78(8):3930-40. PubMed ID: 15047809
[TBL] [Abstract][Full Text] [Related]
13. The uncoupled relationship between the temperature-sensitivity and neurovirulence in mice of mutants of vesicular stomatitis virus.
Rabinowitz SG; Johnson TC; Dal Canto MC
J Gen Virol; 1977 May; 35(2):237-49. PubMed ID: 195006
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis of experimental vesicular stomatitis virus (New Jersey serotype) infection in the deer mouse (Peromyscus maniculatus).
Cornish TE; Stallknecht DE; Brown CC; Seal BS; Howerth EW
Vet Pathol; 2001 Jul; 38(4):396-406. PubMed ID: 11467473
[TBL] [Abstract][Full Text] [Related]
15. Experimental vesicular stomatitis in swine: effects of route of inoculation and steroid treatment.
Howerth EW; Stallknecht DE; Dorminy M; Pisell T; Clarke GR
J Vet Diagn Invest; 1997 Apr; 9(2):136-42. PubMed ID: 9211231
[TBL] [Abstract][Full Text] [Related]
16. The earliest events in vesicular stomatitis virus infection of the murine olfactory neuroepithelium and entry of the central nervous system.
Plakhov IV; Arlund EE; Aoki C; Reiss CS
Virology; 1995 May; 209(1):257-62. PubMed ID: 7747478
[TBL] [Abstract][Full Text] [Related]
17. Recombinant vesicular stomatitis virus vectors as oncolytic agents in the treatment of high-grade gliomas in an organotypic brain tissue slice-glioma coculture model.
Duntsch CD; Zhou Q; Jayakar HR; Weimar JD; Robertson JH; Pfeffer LM; Wang L; Xiang Z; Whitt MA
J Neurosurg; 2004 Jun; 100(6):1049-59. PubMed ID: 15200120
[TBL] [Abstract][Full Text] [Related]
18. Safety studies on intrahepatic or intratumoral injection of oncolytic vesicular stomatitis virus expressing interferon-beta in rodents and nonhuman primates.
Jenks N; Myers R; Greiner SM; Thompson J; Mader EK; Greenslade A; Griesmann GE; Federspiel MJ; Rakela J; Borad MJ; Vile RG; Barber GN; Meier TR; Blanco MC; Carlson SK; Russell SJ; Peng KW
Hum Gene Ther; 2010 Apr; 21(4):451-62. PubMed ID: 19911974
[TBL] [Abstract][Full Text] [Related]
19. Relative neurotropism of a recombinant rhabdovirus expressing a green fluorescent envelope glycoprotein.
van den Pol AN; Dalton KP; Rose JK
J Virol; 2002 Feb; 76(3):1309-27. PubMed ID: 11773406
[TBL] [Abstract][Full Text] [Related]
20. In vivo biodistribution of a highly attenuated recombinant vesicular stomatitis virus expressing HIV-1 Gag following intramuscular, intranasal, or intravenous inoculation.
Johnson JE; Coleman JW; Kalyan NK; Calderon P; Wright KJ; Obregon J; Ogin-Wilson E; Natuk RJ; Clarke DK; Udem SA; Cooper D; Hendry RM
Vaccine; 2009 May; 27(22):2930-9. PubMed ID: 19428903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
